DIPK1A

Across TCGA pan-cancer cohorts, DIPK1A mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated DIPK1A data layer compared with 25 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher DIPK1A mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated DIPK1A expression acts as an unfavorable survival marker.

CCRCC, LUAD, and PDAC are the cancer types where DIPK1A mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Tertile	III,IV	0.219	0.819	.024	11	view →
LUAD	DFS	Median	II,III,IV	0.765	1.000	.022	7	view →
PDAC	OS	Median	IV	0.222	0.962	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

DIPK1A–CCRCC (DFS)

Open the CCRCC breakdown →